Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$3.93 USD
+0.03 (0.77%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $3.92 -0.01 (-0.25%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/7/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | -0.12 |
Last EPS Surprise | -50.00% |
ABR | 1.14 |
Earnings ESP
|
-17.42% |
---|---|
Current Year | -0.36 |
Next Year | -0.32 |
EPS (TTM) | -0.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 12.22M | 12.77M | 50.55M | 56.80M |
# of Estimates | 5 | 5 | 5 | 4 |
High Estimate | 12.80M | 13.10M | 51.83M | 60.21M |
Low Estimate | 10.90M | 12.50M | 50.00M | 49.80M |
Year ago Sales | 11.13M | 13.24M | 50.58M | 50.55M |
Year over Year Growth Est. | 9.79% | -3.58% | -0.07% | 12.36% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.09 | -0.36 | -0.32 |
# of Estimates | 5 | 5 | 5 | 4 |
Most Recent Consensus | -0.12 | -0.10 | -0.38 | -0.30 |
High Estimate | -0.04 | -0.07 | -0.27 | -0.24 |
Low Estimate | -0.12 | -0.11 | -0.42 | -0.41 |
Year ago EPS | 0.11 | -0.10 | -0.13 | -0.36 |
Year over Year Growth Est. | -181.82% | 10.00% | -176.92% | 9.86% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.09 | -0.09 | -0.36 | -0.32 |
7 Days Ago | -0.09 | -0.09 | -0.36 | -0.32 |
30 Days Ago | -0.09 | -0.10 | -0.38 | -0.28 |
60 Days Ago | -0.10 | -0.10 | -0.34 | -0.35 |
90 Days Ago | -0.10 | -0.10 | -0.34 | -0.35 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | -0.09 | -0.37 | -0.35 |
Zacks Consensus Estimate | -0.09 | -0.09 | -0.36 | -0.32 |
Earnings ESP | -17.42% | 0.71% | -2.42% | -8.53% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.12 | -0.03 | -0.10 | 0.11 | NA |
Estimate | -0.08 | -0.11 | -0.11 | -0.10 | NA |
Difference | -0.04 | 0.08 | 0.01 | 0.21 | 0.07 |
Surprise | -50.00% | 72.73% | 9.09% | 210.00% | 60.46% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more